Effects of Modified Glucosamine on the Chondrogenic Potential of Circulating Stem Cells under Experimental Inflammation
暂无分享,去创建一个
R. Di Liddo | R. Di Santo | R. Costi | M. Artico | S. Taurone | V. N. Madia | V. Tudino | Monica Piccione | Carola Cenzi | M. Gasparella | C. De Ponte
[1] Jin-Xuan Shi,et al. The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment , 2023, Frontiers in Immunology.
[2] W. Marczynski,et al. Literature Analysis Regarding the Combination of Substances: Glucosamine + Chondroitin in the Treatment of Osteoarthritis. , 2022, Ortopedia Traumatologia Rehabilitacja.
[3] D. Kelly,et al. Local depletion of proteoglycans mediates cartilage tissue repair in an ex vivo integration model. , 2022, Acta biomaterialia.
[4] T. Lohse,et al. Glucosamine as a Treatment for Osteoarthritis: What If It’s True? , 2022, Frontiers in Pharmacology.
[5] Karan M. Shah,et al. Strategies for Articular Cartilage Repair and Regeneration , 2021, Frontiers in Bioengineering and Biotechnology.
[6] A. Hoffmann,et al. IκBα is required for full transcriptional induction of some NFκB-regulated genes in response to TNF in MCF-7 cells , 2021, NPJ systems biology and applications.
[7] Shuji Mizumoto,et al. Congenital Disorders of Deficiency in Glycosaminoglycan Biosynthesis , 2021, Frontiers in Genetics.
[8] San-Lang Wang,et al. Production of Thermophilic Chitinase by Paenibacillus sp. TKU052 by Bioprocessing of Chitinous Fishery Wastes and Its Application in N-acetyl-D-glucosamine Production , 2021, Polymers.
[9] C. Kaltschmidt,et al. The Transcription Factor NF-κB in Stem Cells and Development , 2021, Cells.
[10] F. Zaucke,et al. The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model , 2021, International journal of molecular sciences.
[11] Z. Shao,et al. Endogenous Repair and Regeneration of Injured Articular Cartilage: A Challenging but Promising Therapeutic Strategy , 2021, Aging and disease.
[12] P. Olczyk,et al. The Diagnostic Usefulness of Circulating Profile of Extracellular Matrix Components: Sulfated Glycosaminoglycans (sGAG), Hyaluronan (HA) and Extracellular Part of Syndecan-1 (sCD138) in Patients with Crohn’s Disease and Ulcerative Colitis , 2021, Journal of clinical medicine.
[13] A. Hettinghouse,et al. Atsttrin Promotes Cartilage Repair Primarily Through TNFR2-Akt Pathway , 2020, Frontiers in Cell and Developmental Biology.
[14] B. Salomon,et al. TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function , 2020, Stem Cell Research & Therapy.
[15] V. Lefebvre,et al. Enhanced Chondrogenic Capacity of Mesenchymal Stem Cells After TNFα Pre-treatment , 2020, Frontiers in Bioengineering and Biotechnology.
[16] G. Herrero-Beaumont,et al. Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation? , 2020, Annals of the Rheumatic Diseases.
[17] W. Khan,et al. The Effects of TNF-alpha Inhibition on Cartilage: a Systematic Review of preclinical studies. , 2020, Osteoarthritis and cartilage.
[18] Hakmo Lee,et al. Glucosamine potentiates the differentiation of adipose-derived stem cells into glucose-responsive insulin-producing cells , 2020, Annals of translational medicine.
[19] Changde Wang,et al. Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis , 2020, Journal of Orthopaedic Surgery and Research.
[20] C. Corciulo,et al. Signaling of the Purinergic System in the Joint , 2020, Frontiers in Pharmacology.
[21] J. Reginster,et al. Glucosamine sulphate: an umbrella review of health outcomes , 2020, Therapeutic advances in musculoskeletal disease.
[22] P. Correia‐de‐Sá,et al. Adenosinergic Signalling In Chondrogenesis And Cartilage Homeostasis: Friend Or Foe? , 2019, Biochemical pharmacology.
[23] N. Jiang,et al. Notch Signaling Regulates MMP-13 Expression via Runx2 in Chondrocytes , 2019, Scientific Reports.
[24] Xiuzhen Gao,et al. Categories and biomanufacturing methods of glucosamine , 2019, Applied Microbiology and Biotechnology.
[25] Z. Li,et al. Effects of Tumor Necrosis Factor Alpha on the Expression of Programmed Cell Death Factor 5 in Arthritis , 2019, Orthopaedic surgery.
[26] W. Tian,et al. Effect of canonical NF-κB signaling pathway on the differentiation of rat dental epithelial stem cells , 2019, Stem cell research & therapy.
[27] Xiaoming Yang,et al. Collagen type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin β1−SMAD1 interaction , 2019, Bone Research.
[28] A. Todeschini,et al. Hexosamine Biosynthetic Pathway and Glycosylation Regulate Cell Migration in Melanoma Cells , 2019, Front. Oncol..
[29] G. Giannini,et al. Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity. , 2018, Journal of medicinal chemistry.
[30] Li Yan,et al. Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory Diseases , 2018, Front. Immunol..
[31] Hong-zhi Ye,et al. Glucosamine promotes chondrocyte proliferation via the Wnt/β-catenin signaling pathway , 2018, International journal of molecular medicine.
[32] Xiao-ping Chen,et al. Extracellular ATP signaling and clinical relevance. , 2017, Clinical immunology.
[33] P. Robbins,et al. Inhibition of NF-κB improves the stress resistance and myogenic differentiation of MDSPCs isolated from naturally aged mice , 2017, PloS one.
[34] O. Kennedy,et al. Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression , 2017, Nature Communications.
[35] R. Scandurra,et al. Chondroprotective activity of N-acetyl phenylalanine glucosamine derivative on knee joint structure and inflammation in a murine model of osteoarthritis. , 2017, Osteoarthritis and cartilage.
[36] I. Nagaoka,et al. Glucosamine Downregulates the IL-1β-Induced Expression of Proinflammatory Cytokine Genes in Human Synovial MH7A Cells by O-GlcNAc Modification-Dependent and -Independent Mechanisms , 2016, PloS one.
[37] J. Coverdale,et al. Influence of oral glucosamine supplementation in young horses challenged with intra-articular lipopolysaccharide. , 2016, Journal of animal science.
[38] C. Little,et al. Reoxygenation enhances tumour necrosis factor alpha-induced degradation of the extracellular matrix produced by chondrogenic cells. , 2016, European cells & materials.
[39] P. Parnigotto,et al. Neuronal commitment of human circulating multipotent cells by carbon nanotube-polymer scaffolds and biomimetic peptides. , 2016, Nanomedicine.
[40] G. Karimi,et al. Molecular mechanisms and biomedical applications of glucosamine as a potential multifunctional therapeutic agent. , 2016, Life sciences.
[41] P. Siljander,et al. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co‐Operation with T cells , 2016, Stem cells.
[42] R. Markwald,et al. Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis , 2015, International journal of cell biology.
[43] F. Jamali,et al. Synthesis and Characterization of a New Peptide Prodrug of Glucosamine with Enhanced Gut Permeability , 2015, PloS one.
[44] D. Saris,et al. Cytokine profiles in the joint depend on pathology, but are different between synovial fluid, cartilage tissue and cultured chondrocytes , 2014, Arthritis Research & Therapy.
[45] Aladdin M. Srour,et al. Microwave assisted synthesis and QSAR study of novel NSAID acetaminophen conjugates with amino acid linkers. , 2014, Organic & biomolecular chemistry.
[46] B. Min,et al. Cartilage extra-cellular matrix biomembrane for the enhancement of microfractured defects , 2014, Knee Surgery, Sports Traumatology, Arthroscopy.
[47] Zong-ping Luo,et al. Rescue of proinflammatory cytokine-inhibited chondrogenesis by the antiarthritic effect of melatonin in synovium mesenchymal stem cells via suppression of reactive oxygen species and matrix metalloproteinases. , 2014, Free radical biology & medicine.
[48] Z. Zuo,et al. Bioavailability enhancement of glucosamine hydrochloride by chitosan. , 2013, International journal of pharmaceutics.
[49] M. Shive,et al. Novel scaffold-based BST-CarGel treatment results in superior cartilage repair compared with microfracture in a randomized controlled trial. , 2013, The Journal of bone and joint surgery. American volume.
[50] Ji Hoon Jeon,et al. Glucosamine-induced reduction of integrin β4 and plectin complex stimulates migration and proliferation in mouse embryonic stem cells. , 2013, Stem cells and development.
[51] Long Liu,et al. Microbial production of glucosamine and N-acetylglucosamine: advances and perspectives , 2013, Applied Microbiology and Biotechnology.
[52] D. Mooney,et al. NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation , 2013, Proceedings of the National Academy of Sciences.
[53] G. Herrero-Beaumont,et al. Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities , 2013, BMC Research Notes.
[54] H. Im,et al. MMP13 is a critical target gene during the progression of osteoarthritis , 2013, Arthritis Research & Therapy.
[55] H. Kwon. Extracellular ATP signaling via P2X(4) receptor and cAMP/PKA signaling mediate ATP oscillations essential for prechondrogenic condensation. , 2012, The Journal of endocrinology.
[56] W. Richter,et al. Proliferation as a requirement for in vitro chondrogenesis of human mesenchymal stem cells. , 2012, Stem cells and development.
[57] A. Mobasheri,et al. Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? , 2012, Arthritis Research & Therapy.
[58] Sai-kun Pan,et al. Preparation of glucosamine by hydrolysis of chitosan with commercial α-amylase and glucoamylase , 2011, Journal of Zhejiang University SCIENCE B.
[59] B. Choudhury,et al. N-Acetylglucosamine Inhibits T-helper 1 (Th1)/T-helper 17 (Th17) Cell Responses and Treats Experimental Autoimmune Encephalomyelitis* , 2011, The Journal of Biological Chemistry.
[60] J. Anderson,et al. A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals , 2010, Diabetes/metabolism research and reviews.
[61] R. Scandurra,et al. 262 A PEPTIDYL-GLUCOSAMINE DERIVATIVE AFFECTS IKKalpha KINASE ACTIVITY IN HUMAN CHONDROCYTES , 2010 .
[62] B. Dijkmans,et al. Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis. , 2010, Osteoarthritis and cartilage.
[63] Chia-Rui Shen,et al. N-Acetylglucosamine: Production and Applications , 2010, Marine drugs.
[64] Takashi Nakamura,et al. Pannexin 3 Regulates Intracellular ATP/cAMP Levels and Promotes Chondrocyte Differentiation* , 2010, The Journal of Biological Chemistry.
[65] I. Nagaoka,et al. Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model. , 2010, Life sciences.
[66] G. Schett,et al. Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNFα single-chain Fv antibody (ESBA105) designed for local therapeutic use , 2009, Annals of the rheumatic diseases.
[67] Annalisa Pasini,et al. Immune Modulation by Mesenchymal Stem Cells , 2008, Transfusion Medicine and Hemotherapy.
[68] Meijing Wang,et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. , 2008, American journal of physiology. Cell physiology.
[69] J. Bradley,et al. TNF‐mediated inflammatory disease , 2008, The Journal of pathology.
[70] C. Cicione,et al. Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes. , 2007, Clinical and experimental rheumatology.
[71] M. Locatelli,et al. Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. , 2007, Osteoarthritis and cartilage.
[72] R. Tuan,et al. Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. , 2007, Osteoarthritis and cartilage.
[73] M. Popp,et al. Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1β , 2006, Arthritis research & therapy.
[74] Michael H Weisman,et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. , 2006, The New England journal of medicine.
[75] Alan Berry,et al. Metabolic engineering of Escherichia coli for industrial production of glucosamine and N-acetylglucosamine. , 2005, Metabolic engineering.
[76] J W Anderson,et al. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[77] K. Heeg,et al. Extracellular ATP induces oscillations of intracellular Ca2+ and membrane potential and promotes transcription of IL-6 in macrophages. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[78] Tomohiro Kato,et al. Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis. , 2004, Clinical and experimental rheumatology.
[79] S. Abramson,et al. Inflammation in osteoarthritis. , 2004, The Journal of rheumatology. Supplement.
[80] T. Aigner,et al. Collagens--structure, function, and biosynthesis. , 2003, Advanced drug delivery reviews.
[81] A. Baldwin,et al. NF-κB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism , 2003 .
[82] M. Uldry,et al. GLUT2 is a high affinity glucosamine transporter , 2002, FEBS letters.
[83] L. Klareskog,et al. Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. , 2002, Rheumatology.
[84] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[85] T. Einhorn,et al. Impaired Intramembranous Bone Formation during Bone Repair in the Absence of Tumor Necrosis Factor-Alpha Signaling , 2001, Cells Tissues Organs.
[86] Eric Lejeune,et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial , 2001, The Lancet.
[87] Thomas Aigner,et al. Articular cartilage and changes in Arthritis: Cell biology of osteoarthritis , 2001, Arthritis Research & Therapy.
[88] D. Felson,et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. , 2000, JAMA.
[89] V. Lefebvre,et al. Potent Inhibition of the Master Chondrogenic FactorSox9 Gene by Interleukin-1 and Tumor Necrosis Factor-α* , 2000, The Journal of Biological Chemistry.
[90] P. Franchimont,et al. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. , 1998, Osteoarthritis and cartilage.
[91] C. Tsourounis,et al. Glucosamine , 1998, Reactions Weekly.
[92] G. Dorn,et al. Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte* , 1997, The Journal of Biological Chemistry.
[93] T. Aigner,et al. Expression of collagen types IX and XI and other major cartilage matrix components by human fetal chondrocytes in vivo. , 1996, Matrix biology : journal of the International Society for Matrix Biology.
[94] M. Fischer,et al. Glucosamine sulfate in osteoarthritis of the knee. , 1994, Osteoarthritis and cartilage.
[95] W. Haase,et al. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. , 1994, Osteoarthritis and cartilage.
[96] T. Aigner,et al. In situ hybridization studies on the expression of type X collagen in fetal human cartilage. , 1991, Developmental biology.
[97] M. Feldmann,et al. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. , 1991, Arthritis and rheumatism.
[98] M. Goldring,et al. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide , 1991, The Journal of cell biology.
[99] E. Vuorio,et al. Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization , 1987, The Journal of cell biology.
[100] J. L. Gordon. Extracellular ATP: effects, sources and fate. , 1986, The Biochemical journal.
[101] S. Gay,et al. Immunochemical and biochemical study of collagen synthesis by chondrocytes in culture. , 1977, Experimental cell research.
[102] F. Cicuttini,et al. Nutrients and Dietary Supplements for Osteoarthritis , 2019, Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases.
[103] C. Pilapil,et al. Interleukin-1 and tumor necrosis factor- α inhibit chondrogenesis by human mesenchymal stem cells through NF- κ B dependent pathways , 2011 .
[104] J. Block,et al. The effects of oral glucosamine on joint health: is a change in research approach needed? , 2010, Osteoarthritis and cartilage.
[105] L. Wells,et al. The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression. , 2010, Current signal transduction therapy.
[106] J. Elisseeff,et al. Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. , 2007, Osteoarthritis and cartilage.
[107] P. Scheurich,et al. Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.
[108] W. Choi,et al. Glucosamine-induced insulin resistance in 3T3-L1 adipocytes. , 2000, American journal of physiology. Endocrinology and metabolism.
[109] G. Scali,et al. Glucosamine sulphate: a controlled clinical investigation in arthrosis. , 1981, Pharmatherapeutica.
[110] A. Bignamini,et al. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. , 1980, Clinical therapeutics.